Possible Insufficiency of Generic Price Competition to Contain Prices for Orally Administered Anticancer Therapies

This study traces the use of the anticancer drug capecitabine through its loss of patent protection to evaluate the effect of generic pricing on the cost of oral anticancer drugs.

Na minha lista:
Bibliografiske detaljer
Udgivet i:JAMA Intern Med
Main Authors: Cole, Ashley L., Sanoff, Hanna K., Dusetzina, Stacie B.
Format: Artigo
Sprog:Inglês
Udgivet: American Medical Association 2017
Fag:
Research Letter
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5820701/
https://ncbi.nlm.nih.gov/pubmed/28892541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.2788
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker